help button home button
AJRCCM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kauffman, H. F.
Right arrow Articles by Koeter, G. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kauffman, H. F.
Right arrow Articles by Koeter, G. K.

Am. J. Respir. Crit. Care Med., Vol 151, No. 6, 06 1995, 2109-2115.

Review of fungus-induced asthmatic reactions

HF Kauffman, JF Tomee, TS van der Werf, JG de Monchy and GK Koeter
Department of Allergology, University Hospital, Groningen, The Netherlands.

Fungus-induced obstructive airway disease in atopic individuals can be differentiated into two categories: first, uncomplicated asthmatic reactions due to high but transient exposure to fungal spores (fungal asthma), resulting in a TH2-type response with immunoglobulin E- mediated reactions and eosinophilic inflammation; and second, a more complex asthmatic reaction due to colonization of the mucus-epithelial surface by virulent protease-producing fungi. The latter condition stimulates as exaggerated immunological response including all subclasses of antibodies directed against the microorganism and an intense eosinophilic infiltrate of the airways. The authors propose that the exaggerated inflammatory response in allergic bronchopulmonary fungosis damages epithelial cells and underlying tissue cells, resulting in inefficient elimination of the microorganisms and damage to matrix proteins of the lung tissue by proteases released by both the fungi and degranulating eosinophils. The positive effects of corticosteroids in the treatment of allergic bronchopulmonary aspergillosis probably results from the dampening of the inflammatory response and an increase of the efficiency of killing the fungi. Sensitization to fungi is high in childhood and declines rapidly with age, suggesting that younger children may be less proficient in clearing fungi from the airways. We propose that insufficient treatment of fungal asthma may result in damage to the bronchial mucosa and formation of bronchiectasis.


This article has been cited by other articles:


Home page
J. Immunol.Home page
S. J. Park, M. T. Wiekowski, S. A. Lira, and B. Mehrad
Neutrophils Regulate Airway Responses in a Model of Fungal Allergic Airways Disease
J. Immunol., February 15, 2006; 176(4): 2538 - 2545.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
Y. Inoue, Y. Matsuwaki, S.-H. Shin, J. U. Ponikau, and H. Kita
Nonpathogenic, Environmental Fungi Induce Activation and Degranulation of Human Eosinophils
J. Immunol., October 15, 2005; 175(8): 5439 - 5447.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
J. M. Schuh, K. Blease, S. L. Kunkel, and C. M. Hogaboam
Eotaxin/CCL11 is involved in acute, but not chronic, allergic airway responses to Aspergillus fumigatus
Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L198 - L204.
[Abstract] [Full Text] [PDF]


Home page
ThoraxHome page
J D Leuppi, S H Downs, S R Downie, G B Marks, and C M Salome
Exhaled nitric oxide levels in atopic children: relation to specific allergic sensitisation, AHR, and respiratory symptoms
Thorax, June 1, 2002; 57(6): 518 - 523.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
A. F. Barker
Bronchiectasis
N. Engl. J. Med., May 2, 2002; 346(18): 1383 - 1393.
[Full Text] [PDF]


Home page
ChestHome page
L. Maiz, M. Cuevas, S. Quirce, J. F. Canon, A. Pacheco, A. Sousa, and H. Escobar
Serologic IgE Immune Responses Against Aspergillus fumigatus and Candida albicans in Patients With Cystic Fibrosis
Chest, March 1, 2002; 121(3): 782 - 788.
[Abstract] [Full Text] [PDF]


Home page
Infect. Immun.Home page
M. C. Noverr, G. B. Toews, and G. B. Huffnagle
Production of Prostaglandins and Leukotrienes by Pathogenic Fungi
Infect. Immun., January 1, 2002; 70(1): 400 - 402.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Blease, C. Jakubzick, J. M. Schuh, B. H. Joshi, R. K. Puri, and C. M. Hogaboam
IL-13 Fusion Cytotoxin Ameliorates Chronic Fungal-Induced Allergic Airway Disease in Mice
J. Immunol., December 1, 2001; 167(11): 6583 - 6592.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. H. DOWNS, T. Z. MITAKAKIS, G. B. MARKS, N. G. CAR, E. G. BELOUSOVA, J. D. LEUPPI, W. XUAN, S. R. DOWNIE, A. TOBIAS, and J. K. PEAT
Clinical Importance of Alternaria Exposure in Children
Am. J. Respir. Crit. Care Med., August 1, 2001; 164(3): 455 - 459.
[Abstract] [Full Text] [PDF]


Home page
Clin. Microbiol. Rev.Home page
S. Sethi and T. F. Murphy
Bacterial Infection in Chronic Obstructive Pulmonary Disease in 2000: a State-of-the-Art Review
Clin. Microbiol. Rev., April 1, 2001; 14(2): 336 - 363.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
E. Marchand, C. Verellen-Dumoulin, M. Mairesse, L. Delaunois, P. Brancaleone, J.-F. Rahier, and O. Vandenplas
Frequency of Cystic Fibrosis Transmembrane Conductance Regulator Gene Mutations and 5T Allele in Patients With Allergic Bronchopulmonary Aspergillosis
Chest, March 1, 2001; 119(3): 762 - 767.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
N. E. Alexis, J. Soukup, S. Nierkens, and S. Becker
Association between airway hyperreactivity and bronchial macrophage dysfunction in individuals with mild asthma
Am J Physiol Lung Cell Mol Physiol, February 1, 2001; 280(2): L369 - L375.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Blease, B. Mehrad, N. W. Lukacs, S. L. Kunkel, T. J. Standiford, and C. M. Hogaboam
Antifungal and Airway Remodeling Roles for Murine Monocyte Chemoattractant Protein-1/CCL2 During Pulmonary Exposure to Asperigillus fumigatus Conidia
J. Immunol., February 1, 2001; 166(3): 1832 - 1842.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
M. C. PASTEUR, S. M. HELLIWELL, S. J. HOUGHTON, S. C. WEBB, J. E. FOWERAKER, R. A. COULDEN, C. D. FLOWER, D. BILTON, and M. T. KEOGAN
An Investigation into Causative Factors in Patients with Bronchiectasis
Am. J. Respir. Crit. Care Med., October 1, 2000; 162(4): 1277 - 1284.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. Blease, B. Mehrad, T. J. Standiford, N. W. Lukacs, J. Gosling, L. Boring, I. F. Charo, S. L. Kunkel, and C. M. Hogaboam
Enhanced Pulmonary Allergic Responses to Aspergillus in CCR2-/- Mice
J. Immunol., September 1, 2000; 165(5): 2603 - 2611.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
T. Eaton, J. Garrett, D. Milne, A. Frankel, and A. U. Wells
Allergic Bronchopulmonary Aspergillosis in the Asthma Clinic : A Prospective Evaluation of CT in the Diagnostic Algorithm
Chest, July 1, 2000; 118(1): 66 - 72.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C. M. Hogaboam, C. S. Gallinat, D. D. Taub, R. M. Strieter, S. L. Kunkel, and N. W. Lukacs
Immunomodulatory Role of C10 Chemokine in a Murine Model of Allergic Bronchopulmonary Aspergillosis
J. Immunol., May 15, 1999; 162(10): 6071 - 6079.
[Abstract] [Full Text] [PDF]


Home page
JEMHome page
G. Grunig, D. B. Corry, M. W. Leach, B. W.P. Seymour, V. P. Kurup, and D. M. Rennick
Interleukin-10 Is a Natural Suppressor of Cytokine Production and Inflammation in a Murine Model of Allergic Bronchopulmonary Aspergillosis
J. Exp. Med., March 17, 1997; 185(6): 1089 - 1100.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Cell Mol. Biol.
Copyright © 1995 American Thoracic Society
  ATS Clinical Skills Tests